Fatty infiltration of the liver: Detection and grading using dual T1 gradient echo sequences on clinical MR system

Gastroenterologie Clinique et Biologique

Volumn 29, Issue 11, 2005, Pages 1143-1147

  Pilleul, Frank ^a   Chave, Géraldine ^a   Dumortier, Jérome ^a   Scoazec, Jean Yves ^a   Valette, Pierre Jean ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; WATER;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DISEASE SEVERITY; EVALUATION; FATTY LIVER; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LINEAR REGRESSION ANALYSIS; LIPID STORAGE; LIVER; LIVER CELL; LIVER REGENERATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; STEATOSIS;

EID: 30044451067     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(05)82179-7     Document Type: Article

References (23)

1. Mac Sween RNM, Burt AD, Portmann PC, Ishak KG, Scheuer PJ, Anthony PP. Pathology the liver. 3nd ed. Edinburgh, Churchill Livingstone, 1994.
2. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
3. James O, Day C. Nonalcoholic steatohepatitis: another disease of affluence. Lancet 1999;353:1634-6.
4. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001;21:3-16.
5. Frankel WL, Tranovich JG, Salter L, Bumgardner G, Baker P. The optimal number of donor biopsy sites to evaluate liver histology for transplantation. Liver Transpl 2002;8:1044-50.
6. Gandon Y, Guyader D, Heautot JF, Reda MI, Yaouanq J, Buhe T, et al. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 1994;193:533-8.
7. Mitchell DG. Focal manifestations of diffuse liver disease at MR imaging. Radiology 1992;185:1-11.
8. Heiken JP, Lee JK, Dixon WT. Fatty infiltration of the liver: evaluation by proton spectroscopic imaging. Radiology 1985;157:707-10.
9. Levenson H, Greensite F, Hoefs J, Friloux L, Applegate G, Silva E, et al. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. Am J Roentgenol 1991;156:307-12.
10. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189-94.
11. Holdstock G, Millward-Sadler GH, Wright R. Hepatic changes in systemic disease. In: Wright R, Alberti KGMM, Karran S, Millward-Sadler GH, eds. Liver and biliary disease. 1st ed. Philadelphia: Sounders WB Ltd., 1979:848.
12. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, et al. Prevalence of chronic liver diseases in the general population of Northern Italy: the Dionysos study. Hepatology 1994;20:1442-9.
13. Teli MR, James OFW, Burt D, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow -up study. Hepatology 1995;22:1714-9.
14. Needleman L, Kurtz AB, Rifkin MD, Cooper HS, Pasto ME, Goldberg BB. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR 1986;146:1011-5.
15. Alpern MB, Lawson TL, Foley WD. Focal hepatic masses and fatty infiltration detected by enhanced dynamic CT. Radiology 1986;158:45-9.
16. Lee JK, Dixon WT, Ling D, Levitt RG, Murphy WA Jr. Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Preliminary observations. Radiology 1984;153:195-201.
17. Jacobs JE, Birnbaum BA, Shapiro MA, Langlotz CP, Slosman F, Rubesin SE, et al. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. Am J Roentgenol 1998;171:659-64.
18. Johnston RJ, Stamm ER, Lewin JM, Hendrick RE, Archer PG. Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurements. Abdominal imaging 1998;23:409-15.
19. Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 1997;15:287-93.
20. Mitchell DG, Kim I, Chang TS, Vinitski S, Consigny PM, Saponaro SA, et al. Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol 1991;26:1041-52.
21. Fishbein MH, Stevens WR. Rapid MRI using a modified Dixon technique: a noninvasive and effective method for detection and monitoring of fatty metamorphosis of the liver. Pediatr Radiol 2001;31:806-9.
22. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-50.
23. Rinella ME, McCarthy R, Thakrar K, Finn JP, Rao SM, Koffron AJ, et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation. Liver Transpl 2003;9:851-6.